Showing results (221-230 of 246) with videos related to
Sort By:
Pageof 25
Clinical and Molecular Hepatology|October 28, 2025
Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular FeaturesWon Suk Lee, Seonjeong Woo, Sung Hwan Lee, et al.Gut|June 10, 2024
PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaFriederike L Keggenhoff, Darko Castven, Diana Becker, et al.Neoplasia (New York, N.Y.)|April 8, 2011
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticlesMian M K Shahzad, Lingegowda S Mangala, Hee Dong Han, et al.Cancer Research|May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsBryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.Science Signaling|May 25, 2017
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Styliani Karanika, Guang Yang, et al.Plos Medicine|December 24, 2014
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validationJi Hoon Kim, Bo Hwa Sohn, Hyun-Sung Lee, et al.Cell Reports. Medicine|September 4, 2025
Epigenetic modulation of BARD1 to enhance anti-VEGF therapyEmine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, et al.Nature Communications|August 23, 2017
Platelets reduce anoikis and promote metastasis by activating YAP1 signalingMonika Haemmerle, Morgan L Taylor, Tony Gutschner, et al.Gastroenterology|June 21, 2011
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapyIain Beehuat Tan, Tatiana Ivanova, Kiat Hon Lim, et al.Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.Pageof 25